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Abstract
Familial forms of Alzheimer’s disease (AD) are caused by mutations in the presenilin genes
or in the gene encoding for the amyloid precursor protein (APP). Proteolytic cleavage of
APP generates the β-amyloid peptide (Aβ), which aggregates into amyloid plaques, one of
the major hallmarks of AD. APP mutations within the Aβ sequence, so-called intra-Aβmuta-
tions, cluster around position E693 of APP, which corresponds to position E22 in the Aβ
sequence. One of these mutations is the Osaka mutation, E693Δ, which has unique aggre-
gation properties with patients showing unusually low brain amyloid levels on amyloid PET
scans. Despite intense research on the pathomechanisms of different intra-Aβmutants, our
knowledge is limited due to controversial findings in various studies. Here, we investigated
in an ex vivo experimental system the neuro- and synaptotoxic properties of two intra-Aβ
mutants with different intrinsic aggregation propensities, the Osaka mutation E22Δ and the
Arctic mutation E22G, and compared them to wild-type (wt) Aβ. Experiments in hippocam-
pal slice cultures from transgenic mice were complemented by treating wild-type slices with
recombinantly produced Aβ40 or Aβ42 containing the respective intra-Aβmutations. Our
analyses revealed that wt Aβ and E22G Aβ, both recombinant and transgenic, caused a
loss of dendritic spines along with an increase in tau phosphorylation and tau-dependent
neurodegeneration. In all experiments, the 42-residue variants of wt and E22G Aβ showed
stronger effects than the respective Aβ40 isoforms. In contrast, E22Δ Aβ neither reduced
dendritic spine density nor resulted in increased tau phosphorylation or neuronal cell death
in our ex vivo system. Our findings suggest that the previously reported major differences in
the aggregation kinetics between E22G and E22Δ Aβ are likely reflected in different disease
pathomechanisms.
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Introduction
Alzheimer’s Disease (AD) is the most common age-related neurodegenerative disorder. The
major histopathological hallmarks are the presence of extracellular aggregates of Aβ in amyloid
plaques and intracellular neurofibrillary tangles containing hyperphosphorylated tau as major
component. According to the amyloid hypothesis Aβ aggregates, especially oligomers, are the
driver of AD pathology [1]. Aβ is generated by proteolytic processing of APP by the β- and γ-
secretase complexes. Familial forms of AD are caused by mutations in presenilin 1 or preseni-
lin 2, the catalytic subunits of the γ-secretase complex, or by mutations in APP itself. APP
mutations can have various effect on APP processing, depending on their location. Mutations
around the β-secretase cleavage site, such as the APPswe mutation K670N/M671L, increase the
general production of Aβ, whereas mutations near the γ-secretase cleavage site shift the pro-
cessing towards longer isoforms of Aβ, such as Aβ42, which is thought to be more toxic than
the shorter Aβ40 variant [2]. Mutations within the Aβ sequence of APP alter the aggregation
propensity of Aβ. A special cluster of these intra-Aβmutations is localized at position E693 of
APP, corresponding to position E22 in the Aβ sequence, a hydrophobic core of the peptide.
Mutations at this position include the Dutch (E693Q) [3], Italian (E693K) [4], Arctic (E693G)
[5] or Osaka (E693Δ) mutation [6].
The Arctic mutation E693G was discovered in 2001 in a Swedish family showing clinical
symptoms of early-onset AD. Carriers of this mutation show decreased Aβ42 and Aβ40 levels
in plasma [5] and low PiB PET retention while cerebral glucose metabolism and CSF levels of
Aβ42, total and phosphorylated tau are highly pathologic [7]. The Osaka mutation E693Δ, dis-
covered in 2008, shows a recessive pattern of inheritance that causes AD-like symptoms
despite very low PiB PET signals [6]. As synthetic E22Δ Aβ was shown not to form fibrils, it
was hypothesized that this mutation favours oligomerization causing AD in the absence of
fibril/plaque formation [6]. However, the literature on the aggregation propensity of the
E693Δmutation is controversial as subsequent studies, including our own research using
recombinant Aβ peptides, showed fibril formation by E22Δ Aβ [8–11]. Compared to wt and
E22G, recombinant E22Δ Aβ 40 and Aβ 42 had unique aggregation characteristics in thioflavin
T aggregation assays with E22Δ Aβ42 forming SDS-resistant amyloid fibrils direct after recon-
stitution, while fibril growth occurred non-exponentially. In contrast, E22Δ Aβ40 aggregation
was characterized by an exponential growth phase [8]. These findings were supported in vivo.
Extracellular accumulation of insoluble Aβ occurred in E22ΔAβ transgenic mice as leptome-
ningeal cerebral amyloid angiopathy at the age of 24 months, while intraneuronal Aβ oligo-
mers were detected already at 3 months. In contrast, arcAβ transgenic mice, expressing E22G
Aβ and Tg2576 mice, which express wt Aβ, accumulated detergent-insoluble, fibrillar aggre-
gates already at 6 month (arcAβmice) and 15 months (Tg2576) of age [8].
Besides several studies on the mechanisms of E22Δ Aβ toxicity, a direct comparison to wt
and E22G Aβ for its neuro- and synaptotoxic properties has not been performed yet. There-
fore, we analyzed the effects of recombinant E22Δ, E22G and wt Aβ40 and Aβ42 on neuronal
survival and dendritic spine densities in an ex vivo experimental paradigm in hippocampal
slice cultures. Treatment of wild-type slices with recombinant Aβ was directly compared to
slices obtained from the respective transgenic mouse models.
We found that both recombinant wt and E22G Aβ42 induced loss of dendritic spines,
increased tau phosphorylation and caused a tau-dependent cell death in wild-type slices. This
was confirmed in slices from Tg2576 and arcAβ transgenic mice. In contrast, neither induction
of toxicity nor an increase in tau phosphorylation were observed in slices treated with E22Δ
Aβ40 or Aβ42 or in slices from E22ΔAβ transgenic mice, suggesting differential disease patho-
mechanisms for distinct intra-Aβmutants.
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Materials andmethods
Animals
ArcAβmice and E22ΔAβmice were obtained as previously described [8, 12]. Tg2576 mice
(B6;SJL-Tg(APPSWE)2576Kha) were obtained from Taconic Biosciences, Rensselaer, NY,
USA. Details on respective APP mutations are displayed in Table 1. All animal experiments
were performed in compliance with Swiss national guidelines and were approved by the veteri-
narian office of the Canton of Zurich. Animals were housed in groups. For preparation of hip-
pocampal slice cultures P6-P8 mice were sacrificed by decapitation.
Organotypic hippocampal slice cultures
Organotypic hippocampal slice cultures were prepared from P6-P8 mice and cultured as previ-
ously described [13], with 3 slices per well. For assessment of dendritic spine density, cultures
were transduced with Sindbis virus expressing EGFP at DIV 12 and were fixed at DIV15 with
4% paraformaldehyde in PBS containing 4% sucrose for 2h at 4˚C. After washing with PBS,
cultures were mounted with Hydromount (National diagnostics, Atlanta, Georgia) and cover-
slipped. For analysis of hTau-dependent toxicity, slices were transduced at DIV 12 with Sind-
bis virus expressing EGFP-coupled human 441 wild-type tau. At DIV 16 culture medium was
harvested for cytotoxicity assays and lysates were prepared for western blot analyses. To deter-
mine the effect of recombinant Aβ on dendritic spines, slices were treated with 1 μM recombi-
nant Aβ from DIV 8 until fixation on DIV 15. For measurement of cell toxicity, 1 μM
recombinant Aβ was applied from DIV 12 until DIV 16. This concentration was chosen as it
was previously shown that 1 μM of recombinant wt Aβ induces significant loss of dendritic
spines and a human tau-dependent neuronal cell death in this experimental system [13].
Recombinant Aβ
Recombinant Aβ was prepared as described previously [8, 9, 14]. For reconstitution, lyophi-
lized Aβ was dissolved in 10 mMNaOH and sonicated for 1 min. Concentration was con-
firmed using Nanodrop (Thermo Scientific) and if necessary, adjusted to the concentration of
62.5 μM using 10 mMNaOH. Before addition to cell culture medium, the Aβ solution was
mixed in neutralization buffer (40 mMHCl, 50mMH3PO4-NaOH pH 7.4, 10 mMNaCl) in a
4:1 ratio yielding a 50 μMAβ solution at pH7.4 which is immediately added to the cell culture
in a 1:50 ratio. For all steps, LoBind tubes (Eppendorf, Germany) were used.
Analysis of dendritic spine density
Apical dendritic segments length in CA1 stratum radiatum were imaged using Leica SP2 con-
focal laserscanning microscope, equipped with 63x objective (NA: 1.2) and 488nm Argon
laser. CA1 apical dendrites were chosen for their straighter appearance compared to CA3 den-
drites, which allows the imaging of a single dendritic segment and a less error-prone counting
of spine numbers per dendrite. Further, it has been shown that Aβ affects spine numbers in
CA1 and CA3 apical dendrites to a similar extent [15]. Images were taken at a size of 30x30 μm
Table 1. APP/Aβmutants used in this study.
Tg2576 mice
[16]
arcAβmice [12] E22ΔAβmice [8] recombinant wt
Aβ





APPswe (K670N + M671L);
APParc (E693G (= E22G))
APPswe (K670N + M671L);
APPosaka (E693Δ (= E22Δ))
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(512x512 pixel, voxel size: 0.05813x0.05813x0.25 μm) with one clearly visible dendritic seg-
ment of 30–40 μm length. Image stacks were processed to maximum projections, regions of
interest were cropped if applicable and dendritic spine density was determined as spine counts
per μm dendrite using ImageJ.
Assessment of cell death
To determine cytotoxicity of Aβ, culture medium was harvested on DIV 16, frozen in liquid
nitrogen and stored at -80˚C until further analysis with CytotoxGlo assay (Promega, Madison,
USA), according to the manufacturer’s recommendations. For measurement of human EGFP-
tau-dependent toxicity, CytotoxGlo signals were normalized to EGFP fluorescence using
microplate reader Synergy HT.
Westernblot analysis
On DIV 16 slices were harvested in RIPA buffer (50 mM Tris-HCl, 150 mMNaCl, 2 mM
EDTA, 1% NP-40, 0.5% deoxycholate, and 0.1% SDS, pH 8.0) containing phosphatase inhibi-
tor cocktails 1 and 2 (Sigma) and protease inhibitor cocktail (Roche) and centrifuged at
5000xg for 10 min at 4˚C. The supernatant was collected, frozen in liquid nitrogen and stored
at -80˚C. Samples were mixed with loading buffer, resolved using 10–20% SDS PAGE and
transferred to nitrocellulose membranes (Millipore). Immunoblotting was performed using
primary antibodies Anti-GFP to detect total EGFP-coupled tau (1:1000, Roche), anti phospho-
Tau AT8 (1:200, Pierce), anti GAPDH (1:5000, Biodesign) and HRP-conjugated secondary
antibody (1:2000, Amersham). Bands were detected using the Supersignal Femto Maximum
Sensitivity Substrate (Thermo) and imaged with Fujifilm Las-3000 assuring that no pixels were
saturated. Band intensities were quantified with ImageJ and corrected for background.
Statistics
Data are presented as mean ± standard deviation (SD). All datapoints (n-numbers) are plotted
individually in each bar graph. Statistical analysis was performed with GraphPad Prism 7.01
software using Shapiro-Wilk test for normal distribution followed by one-way ANOVA with
Tukey’s multiple comparison test. Exact p-values, mean differences and significances for all
experiments are listed in S1 Table. For dendritic spine analysis, n = 1 refers to one image con-
taining one dendritic segment. For cell death assessment, n = 1 represents the analysis of
supernatant of one cell culture well in which 3 hippocampal slices were cultured. For western
blot analysis, n = 1 refers to the lysate of one well, in which 3 hippocampal slices were cultured
and pooled for analysis.
Results
Reduced dendritic spine density in slice cultures from Tg2576 and arcAβ-
but not E22ΔAβ transgenic mice
Loss of pre- and postsynaptic structures is an early feature of AD and directly correlates to the
degree of dementia [17]. Whether different intra-Aβmutations confer a different degree of
synaptotoxicity to Aβ is largely unknown. To determine the differential mechanisms of syn-
apse loss caused by intra-Aβmutants, we applied the well-established organotypic hippocam-
pal slice culture technique [13, 15, 18, 19]. Slices were obtained from i) Tg2576 transgenic
mice, which do not have an intra-Aβmutation thus producing wild-type Aβ, ii) arcAβ trans-
genic mice, producing Aβ with the “Arctic” mutation E22G and iii) E22ΔAβ transgenic mice
with the “Osaka” mutation E22Δ (Table 1). Slices were transduced with EGFP-expressing
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Sindbis virus, allowing high-resolution imaging of dendritic segments and spines [19]. As
shown previously [13], spine density was strongly reduced in slices from arcAβmice compared
to slices from non-transgenic (non-tg) littermates (Fig 1A and 1B). This was rescued by treat-
ment with the γ-secretase inhibitor DAPT at 0.5 μM indicating that spine reduction is medi-
ated by Aβ and showing the validity of the transgenic slice culture model. Slices from Tg2576
mice displayed a similar reduction in spine numbers compared to arcAβ tg mice whereas
Fig 1. Reduction in dendritic spine density in hippocampal slices from Tg2576 and arcAβ- but not E22ΔAβ transgenic
mice. A: Representative confocal images of dendritic segments of hippocampal slices from Tg2576, arcAβ- and E22ΔAβ
transgenic mice and the respective non-transgenic littermates. B: Spine counts per μm dendrite. Spine density was reduced in
cultures from Tg2576 tg mice and arcAβ tg mice but not in E22ΔAβ tg mice. Treatment with 0.5 μMDAPT abolished spine
reduction in arcAβ tg slices. n = 10–12; Data are means ± SD. Statistical significance was assessed by one-way ANOVA with
Tukey’s multiple comparison test (���p<0.001). Scale bar: 5 μm.
https://doi.org/10.1371/journal.pone.0239584.g001
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E22ΔAβ tg slices showed no differences to their non-tg control (E22ΔAβ wt). A detailed list of
all p-values is presented in S1 Table.
Recombinant wt and E22G Aβ but not E22Δ Aβ reduce dendritic spine
density
To confirm the results obtained in slices from the transgenic mice, we used wild-type slices
treated with recombinant Aβ containing the respective intra-Aβmutations. Recombinant Aβ
was produced in Escherichia coli with higher purity than commercially available synthetic Aβ
[14]. Wt, E22G and E22Δ Aβ were tested at a concentration of 1 μM as 40- and 42-residue iso-
forms. Treatment with wt Aβ42 and E22G Aβ42 but not E22Δ Aβ42 induced a strong reduc-
tion in dendritic spine density compared to untreated and vehicle treated slices (Fig 2A and
2B). Interestingly, the degree of spine loss caused by wt Aβ42 and E22G Aβ42 was similar to
the spine loss observed in slices from the respective transgenic mouse model (Fig 1). Wt Aβ40
and E22G Aβ40 caused spine loss to a lesser extent, with wt Aβ40 not reaching significance
(p = 0.06). E22Δ Aβ40 did not show an effect on spine density. A direct comparison between
the 40- and 42-residue isoforms showed that E22G Aβ42 reduced spine numbers significantly
more than E22G Aβ40 (S1A Fig). While spine reduction upon wt Aβ42 treatment was similarly
stronger than upon treatment with wt Aβ40 treatment, this difference did not reach signifi-
cance (p = 0.059). However, no difference was observed between E22Δ Aβ42 and Aβ40
(p = 0.909) (S1A Fig) with both isoforms showing no significant effect on dendritic spines.
Wt and E22G Aβ but not E22Δ Aβ induce of tau phosphorylation and tau-
dependent cell death
We and others have shown that Aβ induces cell death, depending on the presence of tau [20],
especially of human tau [15]. To determine whether intra-Aβmutations confer different levels
of toxicity to Aβ, we first used slices from Tg2576, arcAβ tg and E22ΔAβ tg mice, and virally
expressed the 441 isoform of human tau, coupled to EGFP. Toxicity was determined using
CytotoxGlo assay, measuring dead-cell protease activity released from cells that have lost
membrane integrity (Fig 3A). A significantly higher toxicity was observed in slices from
Tg2576 mice compared non-tg littermates. Higher signals were also found in arcAβ tg com-
pared to non-tg slices, although this did not reach significance (p = 0.058). No difference was
observed between slices from E22ΔAβ tg and non-tg littermates (p = 0.843).
To support this finding, slices from wild-type mice expressing human tau were treated with
1 μM recombinant Aβ (Fig 3B). Similar to the findings in transgenic cultures, wt Aβ42 and
E22G Aβ42 treatment increased toxicity compared to untreated and vehicle treated slices. Wt
Aβ40 and E22G Aβ40 did not induce toxicity. E22Δ Aβ42 and E22Δ Aβ40 both did not affect
cell viability in this setting, confirming the results from E22ΔAβ tg cultures. A direct compari-
son between the 40- and 42-residue isoforms showed that wt Aβ42 and E22G Aβ42 were sig-
nificantly more toxic than wt Aβ40 and E22G Aβ40, respectively, whereas no difference was
observed between E22Δ Aβ42 and E22Δ Aβ40 (p = 0.688) (S1B Fig). To further confirm that
Aβ toxicity is mediated by the presence of human tau, wild-type slices were treated with 1μM
recombinant Aβ in the absence of human tau expression (Fig 3C). In this case, no Aβ toxicity
was observed.
Is has been shown that Aβ can activate tau kinases thereby increasing tau phosphorylation
which induces cell death downstream of Aβ [15, 21]. We determined the level of tau phosphor-
ylation at the AT8 epitope, in cultures treated with wt Aβ42, E22G Aβ42 or E22Δ Aβ42 (Fig
3D). In line with our findings on cell toxicity, only wt Aβ42 and E22G Aβ42 but not E22Δ
Aβ42 significantly increased tau phosphorylation.
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Fig 2. Reduction in dendritic spine density in hippocampal slices treated with recombinant wt and E22G Aβ but
not E22Δ Aβ. A: Representative confocal images of dendritic segments of wild-type mice treated with 1 μM
recombinant Aβ for 7 days. B: Spine counts per μm dendrite. Spine density was reduced after treatment with wt Aβ42
and E22G Aβ42 but not E22Δ Aβ42. Incubation with wt Aβ40 and E22G Aβ40 caused a mild reduction in spine
numbers, whereas no effect was observed for E22Δ Aβ40. n = 10–15; Data are means ± SD. Statistical significance was
assessed by one-way ANOVAwith Tukey’s multiple comparison test (�p<0.05; ���p<0.001). Scale bar: 5 μm.
https://doi.org/10.1371/journal.pone.0239584.g002
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Taken together, wt and E22G Aβ –either recombinant or transgenic–but not E22Δ Aβ
increased tau phosphorylation and tau-dependent cell death.
Discussion
In this study, we showed that the Osaka intra-Aβmutation E693Δ did not confer toxic proper-
ties to Aβ in an ex vivo tissue culture model, compared to the Arctic intra-Aβmutation E693G
and to wt Aβ. We used either wild-type organotypic hippocampal slices treated with recombi-
nant preparations of wt, E22G or E22Δ Aβ42 or Aβ40 or slices cultured from the respective
transgenic mouse model, i.e. Tg2576, arcAβ and E22ΔAβmice (Table 1). All mouse lines
express APPswe under the control of the prion protein promoter and differ only in the intra-
Aβmutation at position 22. Expression levels of APP are identical in these mice [8]. Several
studies on E22Δ aggregation or toxicity used synthetic Aβ peptides. However, synthetically
produced Aβ is often contaminated with up to 9% impurities, such as racemized peptides, that
cannot be avoided due to the technical limitations of peptide synthesis [9, 14]. Importantly,
impurities in synthetic Aβ already in the range of 3% were previously shown to have a signifi-
cant impact on its aggregation properties [9, 14]. The use of recombinant Aβ can bypass this
limitation and it has been shown that recombinantly produced Aβ aggregates faster and is
more toxic than synthetic Aβ [14]. In a previous study, we compared the aggregation propen-
sity of recombinant wt, E22G and E22Δ Aβ42 and Aβ40 and found unique aggregation charac-
teristics of E22Δ Aβ42 and Aβ40 [8]. Compared to E22G and wt Aβ, E22Δ Aβ42 displayed
highest fibrillogenesis propensity as it aggregated without a lag phase in a thioflavin T assay
and formed SDS-stable high molecular weight aggregates directly after reconstitution whereas
fibril growth after reconstitution occurred slowly and non-exponentially. Thus, addition of
recombinant E22Δ Aβ to our slice cultures may have caused rapid formation of less toxic fibrils
in the extracellular space, which may explain the lack of toxicity in this setting (see also discus-
sion below).
Loss of pre- and postsynaptic contacts is a major correlate to the degree of dementia in AD
[17]. We showed that recombinant wt Aβ42 and E22G Aβ42 strongly reduced the numbers of
dendritic spines in slice cultures while wt Aβ40 and E22G Aβ40 only had a mild effect. As Aβ
treatment in the absence of human tau expression is not toxic in our model, the reduction in
dendritic spine density represents a distinct pathophysiological event caused by Aβ rather than
a general toxic effect. Importantly, the degree of spine loss in the Aβ42-treated wild-type slices
was similar to spine loss in slices from the respective transgenic mice, confirming that the
treatment with recombinant Aβ can mirror the effects of Aβ produced from processing of
APP. Further, the protective effect of γ-secretase inhibitor DAPT indicates that the synapto-
toxic events in these transgenic cultures were indeed caused by Aβ. In contrast to wt and E22G
Aβ, dendritic spine loss was neither observed in wild-type slices treated with recombinant
E22Δ Aβ42 or Aβ40 nor in slices from E22ΔAβ transgenic mice. This is opposed to a study
which showed that synthetic E22Δ Aβ caused loss of synaptophysin signals in stained slice
Fig 3. Induction of tau phosphorylation and tau-dependent cell death by wt and E22G Aβ but not E22Δ Aβ. A: Cytotoxicity in human tau
expressing slices from Tg2576, arcAβ- and E22ΔAβ tg mice and the respective non-transgenic littermates, measured with CytotoxGlo assay.
Increased cell death was observed in Tg2576 and arcAβ tg slices, although not significant in arcAβ tg slices, but not in E22ΔAβ tg slices. n = 9–16. B:
Cytotoxicity in human tau expressing slices from wild-type mice treated with 1 μM recombinant Aβ. Treatment with wt Aβ42 and E22G Aβ42 but
not E22Δ Aβ42, wt Aβ40, E22G Aβ40 or E22Δ Aβ40 increased cell death. n = 8–10 C: Cytotoxicity in slices from wild-type mice treated with 1 μM
recombinant Aβ, in the absence of human tau expression. No toxicity was observed by wt Aβ42, E22G Aβ42 or E22Δ Aβ42 in the absence of human
tau. n = 5. D: Representative western blot (left) of lysate of human tau expressing wild-type slices, treated with 1 μM recombinant Aβ, displaying total
human tau, phospho-tau at the AT8 epitope and GAPDH. Quantification (right) of western blots showed increased tau phosphorylation after
treatment with wt Aβ42 and E22G Aβ42 but not E22Δ Aβ42. n = 4. Data are means ± SD. Statistical significance was assessed by one-way ANOVA
with Tukey’s multiple comparison test (�p<0.05; ��p<0.01, ���p<0.001).
https://doi.org/10.1371/journal.pone.0239584.g003
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cultures [22], although treatment with 1 μM synthetic Aβ42 did not cause a significant reduc-
tion in the synaptophysin signal in that study. Further, primary cultures transfected with
E693Δ APP showed a loss of dendritic spine numbers compared to wt APP transfected cells
[23]. These discrepancies to our data may be explained by the different techniques used. As
discussed above, synthetic and recombinant Aβ have different aggregation kinetics probably
leading to different types of aggregates. Further, lipofected primary neurons strongly differ
from transgenic slice cultures due do differential expression levels, time-course of expression
and different properties of tissue and dissociated cultures (see below). Third, our transgenic
models bear the APPswemutation in addition to the intra-Aβmutation, which increases total
Aβ production. Nevertheless, we did not observe any effect on spine density in cultures from
E22ΔAβ transgenic mice. In addition to the number of spines, spine morphology has been
shown to be affected in AD models [24]. Primary neurons transfected with E693Δ APP dis-
played a specific loss of mushroom-shaped spines, but not of stubby or thin spines [23]. A loss
of mushroom spines was also observed in APPSDL transgenic slice cultures, which produce Aβ
with the E693Q (Dutch) mutation [15, 25], as well as in hippocampal neurons treated with wt
Aβ oligomers [26]. However, both studies also showed that loss of mushroom spines was
accompanied by an increase in the fraction of stubby spines, indicating a transition from
mushroom to stubby shape rather than a specific loss of mushroom spines. Nevertheless, a
direct comparison of the different Aβmutants and their effect on spine morphology in the
same experimental system should be performed in the future.
Beside the loss of synapses, massive neurodegeneration is characteristic for AD. Previous
studies from our lab showed that both transgenically produced Aβ and treatment with recom-
binant wt Aβ induced neurodegeneration in slice cultures, which was prominent in the pres-
ence of human tau expression [13, 15]. Here, we showed that wt and E22G Aβ induced a tau-
dependent cell death. As tau was expressed using neurotrophic Sindbis virus, we conclude that
the affected cells were primarily neurons. In contrast, E22Δ Aβ did not show induction of tox-
icity. The absence of neurotoxocity is likely due to the the lack of induced tau phosphorylation
by E22Δ Aβ. While wt Aβ42 and E22G Aβ42 massively increases AT8 phosphorylation of tau,
treatment with E22Δ Aβ42 did not elevate phospho-tau signals above baseline. The AT8 epi-
tope (Ser202/The205) is a major phosphorylation site in AD and used to classify the degree of
AD pathology into different Braak stages [27]. Increased phosphorylation, among others at the
AT8 epitope, has been shown to confer toxic properties to tau [13, 15]. Our data is in line with
studies from other labs in which synthetic wt Aβ42 caused a strong MTT reduction in N2a and
IMR-32 cells, while E22Δ Aβ42 only caused a slight reduction in MTT signal [22]. Further,
treatment of primary rat cortical cultures with synthetic wt and E22P Aβ42 but not E22Δ Aβ40
or Aβ42 reduced cell survival [28]. Ovchinnikova and colleagues compared the toxicity of
recombinant wt and E22Δ Aβ40 and Aβ42 [9]. When added to primary neuronal cultures wt
Aβ42 strongly induced LDH release, while E22Δ Aβ42 did not affect cell survival. Interestingly,
E22Δ Aβ40 showed a detectable cell toxicity, although not as strong as wt Aβ42. The reason
why we did not observe cell toxicity of E22Δ Aβ40 may be explained by the use of a lower con-
centration (1 μM compared to 7.4 μM) and the use of an ex vivo tissue culture model. From
our experience primary dissociated neuronal cultures are generally more susceptible to toxic
insults than tissue cultures. In contrast to the lack of tau phosphorylation and tau-dependent
cell death in our study, Umeda and colleagues found exacerbated tau pathology in APPosk-
hTau double transgenic mice [29], suggesting that in vivo E22Δ Aβmay well affect tau biology.
However, the study did not compare APPosk-hTau transgenic mice to APPwt-hTau transgenic
mice or APParc-hTau transgenic mice. Although speculative, APPwt-hTau or APParc-hTau
mice may have shown a stronger tau pathology than APPosk-hTau.
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Taken together, we observed synaptic loss, tau phosphorylation and neuronal degeneration
induced by wt and E22G Aβ, both in a transgenic model and in a recombinant form, while
E22Δ Aβ did not display any effects. Nevertheless, the lack of toxicity of E22Δ Aβ in our model
requires further explanation. We showed differential aggregation properties of recombinant
E22Δ Aβ in our previous study [8]. The type of E22Δ Aβ oligomers which cause neuronal
degeneration and synaptic loss in AD patients with the Osaka APP mutations my either not be
present in our model (see also discussion above on aggregation propensity of recombinant
E22Δ Aβ) or it may appear in the wrong localization. It has been speculated that E22Δ Aβ olig-
omers predominantly accumulate intra-neuronally and exert their toxic effects from inside the
cell [30]. In line, Kondo and colleagues found intracellular Aβ oligomers in induced pluripo-
tent stem cell-derived neurons from E693Δ AD patients but not in patients with the V717F
APP mutation [31]. They hypothesized, that the pathophysiologic heterogeneity in ADmay be
due to the differential presence of intracellular Aβ oligomers. Hence, familial AD caused by
E693Δ would belong to the intraneuronal-type of AD. E22ΔAβ tg mice, used in our study, dis-
play intraneuronal Aβ aggregates, associated with cognitive deficits, at 3 months of age [8].
However, as our slice cultures were prepared from P6-8 mice and cultured for 2 weeks, we do
not expect the presence of intracellular Aβ accumulation, which may explain the lack of toxic-
ity in this model. Interestingly, arcAβ (E22G) transgenic mice also accumulate intraneuronal
Aβ, although at a later time point than E22ΔAβ tg mice. Nevertheless, we previously showed
that wt and E22G Aβ toxicity depends on NMDA receptor signalling and that treatment of
arcAβ transgenic cultures with anti-Aβ antibodies rescued Aβ toxicity, clearly indicating that
both wt and E22G Aβ at least have an extracellular phase in their toxicity mechanisms [13, 15].
Collectively, our findings therefore support the hypothesis of an intraneuronal toxicity mecha-
nism by E22ΔAβ.
Pitfalls/limitations
We are aware that the main conclusion of our study, that E22G and E22Δ Aβ work via differ-
ent mechanisms caused by differential aggregation properties and potential different localiza-
tion of the aggregates, is only shown indirectly. A direct measure would be the analysis of Aβ
aggregates and their localization in the slice culture model. However, our study was affected by
a limited access to animals and tissue, that did not allow for further analysis Aβ aggregates or
localization. Nevertheless, we base our conclusions on a combination of data obtained in the
present study and of data from previous publications, where we showed differential properties
and aggregation kinetics of wt, E22G and E22Δ Aβ in vitro and in vivo [8]. Thus, we are con-
vinced that the conclusion drawn here are valid, however with taking the above-mentioned
limitations into account.
Supporting information
S1 Table. P-values, mean differences and significances for all experiments.
(PDF)
S1 Fig. Comparison of spine loss and cell toxicity between the 40- and 42-residue variants
of recombinant wt, E22G and E22Δ Aβ. These graphs summarize the findings of Figs 2B and
3B and were plotted to better compare the effects of wt Aβ42, E22G Aβ42 and E22Δ Aβ42 to
the respective 40-residue variant, wt Aβ40, E22G Aβ40 and E22Δ Aβ40. A: Spine counts
per μm dendrite. Spine density reduction after treatment with wt Aβ42 and E22G Aβ42 was
higher compared to wt Aβ40 and E22G Aβ40, respectively. No difference was observed
between E22Δ Aβ42 and E22Δ Aβ40. n = 10–15 B: Cytotoxicity in human tau-expressing slices
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from wild-type mice treated with 1 μM recombinant Aβ. Wt Aβ42 and E22Δ Aβ42 induced
more cytotoxicity than wt Aβ40 and E22G Aβ40. No difference was observed between E22Δ
Aβ42 and E22Δ s1Aβ40. n = 8–10. Data are means ± SD. Statistical significance was assessed
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